Federated Hermes’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.6M Sell
109,895
-4,034
-4% -$1.16M 0.05% 374
2025
Q4
$34.5M Sell
113,929
-12,208
-10% -$3.81M 0.06% 334
2025
Q3
$35.4M Sell
126,137
-921
-0.7% -$251K 0.06% 328
2025
Q2
$30.7M Sell
127,058
-13,192
-9% -$3.12M 0.06% 348
2025
Q1
$34.2M Buy
140,250
+2,689
+2% +$809K 0.07% 305
2024
Q4
$45.2M Buy
137,561
+16,338
+13% +$5.55M 0.1% 256
2024
Q3
$40.6M Buy
121,223
+26,787
+28% +$8.51M 0.09% 273
2024
Q2
$25.8M Buy
94,436
+4,253
+5% +$1.24M 0.06% 342
2024
Q1
$31.2M Buy
90,183
+10,693
+13% +$3.52M 0.07% 319
2023
Q4
$25.7M Buy
79,490
+17,762
+29% +$5.57M 0.06% 335
2023
Q3
$22.1M Buy
61,728
+15,871
+35% +$6.12M 0.06% 345
2023
Q2
$17.4M Sell
45,857
-2,343
-5% -$953K 0.04% 420
2023
Q1
$23.1M Buy
48,200
+10,661
+28% +$4.99M 0.06% 351
2022
Q4
$15.8M Sell
37,539
-4,178
-10% -$1.69M 0.04% 433
2022
Q3
$17.4M Sell
41,717
-2,272
-5% -$1.13M 0.05% 417
2022
Q2
$21.8M Buy
43,989
+7,318
+20% +$3.81M 0.06% 369
2022
Q1
$20.7M Sell
36,671
-18,351
-33% -$11.1M 0.05% 432
2021
Q4
$41.6M Buy
55,022
+978
+2% +$732K 0.08% 311
2021
Q3
$40.3M Sell
54,044
-732
-1% -$548K 0.08% 329
2021
Q2
$35.3M Sell
54,776
-15,303
-22% -$9.31M 0.07% 353
2021
Q1
$40M Sell
70,079
-3,736
-5% -$2.21M 0.08% 324
2020
Q4
$43M Sell
73,815
-2,706
-4% -$1.54M 0.09% 283
2020
Q3
$39.4M Sell
76,521
-8,256
-10% -$4.18M 0.09% 250
2020
Q2
$38.3M Sell
84,777
-47,755
-36% -$21.1M 0.1% 253
2020
Q1
$46.5M Sell
132,532
-19,631
-13% -$7.22M 0.14% 168
2019
Q4
$56.3M Sell
152,163
-25,266
-14% -$8.91M 0.13% 195
2019
Q3
$59M Sell
177,429
-4,212
-2% -$1.37M 0.15% 166
2019
Q2
$56.8M Sell
181,641
-3,995
-2% -$1.2M 0.14% 169
2019
Q1
$56.7M Sell
185,636
-21,904
-11% -$5.91M 0.14% 159
2018
Q4
$48.2M Sell
207,540
-30,022
-13% -$8.06M 0.13% 164
2018
Q3
$74.4M Buy
237,562
+226,667
+2,080% +$70.4M 0.17% 128
2018
Q2
$3.14M Buy
10,895
+2,930
+37% +$809K 0.01% 837
2018
Q1
$1.99M Sell
7,965
-119
-1% -$30.3K 0.01% 960
2017
Q4
$1.93M Sell
8,084
-1,190
-13% -$288K 0.01% 950
2017
Q3
$2.06M Sell
9,274
-512
-5% -$115K 0.01% 904
2017
Q2
$2.21M Sell
9,786
-667
-6% -$145K 0.01% 861
2017
Q1
$2.08M Buy
10,453
+1,833
+21% +$353K 0.01% 894
2016
Q4
$1.57M Sell
8,620
-3,185
-27% -$543K ﹤0.01% 965
2016
Q3
$1.93M Buy
11,805
+2,991
+34% +$454K 0.01% 858
2016
Q2
$1.26M Sell
8,814
-2,062
-19% -$294K ﹤0.01% 1022
2016
Q1
$1.49M Sell
10,876
-7,334
-40% -$963K ﹤0.01% 961
2015
Q4
$2.52M Sell
18,210
-3,788
-17% -$525K 0.01% 773
2015
Q3
$2.96M Buy
21,998
+4,115
+23% +$592K 0.01% 723
2015
Q2
$2.69M Buy
17,883
+898
+5% +$128K 0.01% 809
2015
Q1
$2.3M Buy
16,985
+2,564
+18% +$318K 0.01% 916
2014
Q4
$1.74M Sell
14,421
-7,057
-33% -$812K 0.01% 1006
2014
Q3
$2.44M Buy
21,478
+983
+5% +$116K 0.01% 888
2014
Q2
$2.45M Buy
20,495
+5,510
+37% +$673K 0.01% 868
2014
Q1
$1.92M Sell
14,985
-7,800
-34% -$1,000K 0.01% 964
2013
Q4
$2.82M Sell
22,785
-1,037
-4% -$126K 0.01% 804
2013
Q3
$2.8M Buy
23,822
+11,304
+90% +$1.33M 0.01% 791
2013
Q2
$1.41M Buy
+12,518
New +$1.47M 0.01% 1001

Other funds holding BIO